Skip to Content

E613 E613 (Hydroxyzine Pamoate 25 mg)

Pill with imprint E613 E613 is Green, Capsule-shape and has been identified as Hydroxyzine Pamoate 25 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Hydroxyzine is used in the treatment of anxiety; sedation; allergies; allergic urticaria; interstitial cystitis (and more), and belongs to the drug classes antihistamines, miscellaneous anxiolytics, sedatives and hypnotics. FDA has not classified the drug for risk during pregnancy. Hydroxyzine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for E613 E613

Hydroxyzine pamoate 25 mg E613 E613
Hydroxyzine pamoate 25 mg E613 E613
Hydroxyzine pamoate 25 mg E613 E613

Hydroxyzine Pamoate

Imprint:
E613 E613
Strength:
25 mg
Color:
Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antihistamines
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00185-0613

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide